| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 29/06/2023 | 13h01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 28/06/2023 | 13h01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 16/06/2023 | 22h35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 16/06/2023 | 22h35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 16/06/2023 | 22h31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 13/06/2023 | 16h32 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 12/06/2023 | 23h01 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 09/06/2023 | 15h02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 01/06/2023 | 22h02 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 24/05/2023 | 15h31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 23/05/2023 | 15h31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 11/05/2023 | 23h23 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 11/05/2023 | 23h21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 02/05/2023 | 22h05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 28/04/2023 | 23h17 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 28/04/2023 | 23h16 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 28/04/2023 | 23h12 | Edgar (US Regulatory) | Annual Report to Security Holders (ars) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 21/04/2023 | 23h14 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 20/04/2023 | 14h10 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 17/04/2023 | 17h10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 23h01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 14/04/2023 | 22h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 12/04/2023 | 13h02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
